Benzenediols
Apexbio Technology LLC 4-BUTYLRESORCINOL-100MG
4-Butylresorcinol (CAS No 18979-61-8) is a compound prominently used in the biomedical research field particularly in dermatological studies It originates from the class of resorcinols and acts as an inhibitor of tyrosinase reducing melanin synthesis by targeting pathways involved in pigmentation This mechanism makes it a subject of interest for investigations into skin lightening and hyperpigmentation treatments In vitro activity is observed in the nanomolar to low micromolar range indicating high potency Typical applications include studies on various cell models like melanocytes and keratinocytes as well as in vivo animal studies to explore its therapeutic potential in skin disorders It is also utilized in drug screening processes to assess its efficacy and safety profile Experimental concentrations typically depend on the specific research design adjusted according to the study s requirements
Medchemexpress LLC Hydroquinone impurity 1 | 127175-62-6 | MFCD31694262 | 25mg
Hydroquinone impurity 1 is an impurity of Hydroquinone (HY-B0951)
Medchemexpress LLC 4-Fluororesorcinol | 103068-41-3 | 128.10 | 1 ML
4-Fluororesorcinol is a precursor utilized in the creation of fluorescent dyes or indicators, including compounds like fluorescein, coumarin, and various resorcinol analogues.
- Precursor for fluorescent dyes and indicators.
- Used in the preparation of fluorescein.
- Used in the preparation of coumarin.
- Used in the preparation of resorcinol analogues.
Aobchem Hydroquinone diglycidyl ether | ≥95% | CAS 2425-01-6 | C12H14O4 | 5g
Hydroquinone diglycidyl ether | ≥95% | CAS 2425-01-6 | C12H14O4 | 5g
Medchemexpress LLC 1,1'-biphenyl-2,5-diol | 1079-21-6 | MFCD00002342 | 99.2% | 186.21 | C12H10O2 | 1 G
Phenylhydroquinone (2-phenylhydroquinone; CAS 1079-21-6) is a small-molecule research reagent that induces thymic atrophy and up-regulates apoptosis via p53 activation. It is supplied as a high-purity solid for use in in vitro and in vivo studies of apoptosis, thymic function, and related signaling pathways.
- Orally active thymic atrophy inducer.
- Modulates apoptosis through p53 activation.
- High purity suitable for biological research.
- Available in small-scale quantities for laboratory studies.
- Chemically characterized: C12H10O2; MW 186.21.
Medchemexpress LLC 5-methoxyresorcinol | 2174-64-3 | MFCD00002285 | 99.6% | 140.14 g/mol | C7H8O3 | 250 MG
5-Methoxyresorcinol is a phenolic compound provided as a laboratory standard and synthetic intermediate. Supplied as an off-white to yellow solid with a reported purity of 99.63%, it is suitable for analytical reference, method development, and use in organic synthesis.
- Off-white to yellow solid physical form.
- Reported purity of 99.63% suitable for analytical work.
- Commonly used as an analytical standard and synthetic intermediate.
- Soluble in DMSO for preparation of concentrated stock solutions.
- Available in small pack sizes appropriate for bench-scale research.
Medchemexpress LLC 4-Fluororesorcinol | 103068-41-3 | 128.10 | 500 MG
4-Fluororesorcinol is a precursor used in the preparation of fluorescent dyes or indicators. It is suitable for research applications, contributing to the synthesis of compounds such as fluorescein, coumarin, and resorcinol analogues.
- Precursor for fluorescent dyes and indicators
- Suitable for research use only
- Used in the preparation of fluorescein, coumarin, and resorcinol analogues
Medchemexpress LLC Methylhydroquinone | 95-71-6 | 99.9% | 124.14 | 500 G
Methylhydroquinone is an orally active COX inhibitor with IC50s of 480.7 μM for ovine COX-1 and 52.2 μM for human recombinant COX-2. It has potential DNA damaging effects by inhibiting COX-1 to reduce prostaglandin synthesis and induce anti-inflammatory activity, and by inducing DNA single-strand breaks. Methylhydroquinone exerts its effects by competitively binding to the active sites of COX-1 (such as Tyr385, Met522) and non-covalent interactions.
- Orally active COX inhibitor
- IC50s of 480.7 μM for ovine COX-1 and 52.2 μM for human recombinant COX-2
- Potential DNA damaging effects, including inducing DNA single-strand breaks
- Exerts effects by competitively binding to active sites of COX-1 and non-covalent interactions
- Induces DNA single-strand breaks and increases ornithine deoxycholate (ODC) activity and repetitive DNA synthesis (RDS) in rat gastric pyloric mucosa
Medchemexpress LLC Methylhydroquinone | 95-71-6 | 99.9% | 124.14 | 1 KG
Methylhydroquinone is an orally active COX inhibitor with IC50s of 480.7 μM and 52.2 μM for ovine COX-1 and human recombinant COX-2, respectively. It has potential DNA damaging effects by inhibiting COX-1 to reduce prostaglandin synthesis and exert anti-inflammatory activity, and by inducing DNA single-strand breaks. Methylhydroquinone exerts its effects by competitively binding to the active sites of COX-1 (such as Tyr385, Met522) and non-covalent interactions. For research use only.
- Orally active COX inhibitor
- Inhibits COX-1 to reduce prostaglandin synthesis
- Exerts anti-inflammatory activity
- Induces DNA single-strand breaks
- Competitively binds to active sites of COX-1
- Non-covalent interactions
- Suitable for research use